Deerfield Management Company »

Sana Biotechnology shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Sana Biotechnology (SANA) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Sana Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Sana Biotechnology held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sana Biotechnology by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $51k 13k 4.08

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Sana Biotechnology

Flagship Ventures Management
Baillie Gifford & Co
Vanguard Group
T. Rowe Price Associates
Crestline Management
Alphabet
Millennium Management
Baker Bros. Advisors
Partner Fund Management
Jpmorgan Chase & Co
Massachusetts Financial Services
Omega Fund Management
Goldman Sachs Group
Charles Schwab Investment Management
Arrowpoint Asset Management

View all funds holding Sana Biotechnology